CAR-T

Delve into the world of CAR-T in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on CAR-T to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise
CompanyDeals

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise

Biohaven Ltd. (NYSE: BHVN) announced that it has entered into a strategic licensing and collaboration agreement with Japan's Ono Pharmaceutical Co., Ltd. (TYO: 4528). Under the agreement, Ono will obtain…

Mirxes Partners with Thailand's National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs "Cancer Moonshot 2056"

Mirxes Partners with Thailand’s National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs “Cancer Moonshot 2056”

Huadong Medicine's Doer Bio Wins NMPA Clearance to Trial DR30206 – Tri‑Target PD‑L1/VEGF/TGF‑β Fusion Protein Advances into Stage III NSCLC Consolidation Therapy

Huadong Medicine’s Doer Bio Wins NMPA Clearance to Trial DR30206 – Tri‑Target PD‑L1/VEGF/TGF‑β Fusion Protein Advances into Stage III NSCLC Consolidation Therapy

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CARsgen Therapeutics' CT0596 Shows Promising Results in Early Clinical Study
CompanyDrug

CARsgen Therapeutics’ CT0596 Shows Promising Results in Early Clinical Study

IASO Biotherapeutics' Fucaso Granted Orphan Drug Designation by SFDA for Multiple Myeloma
CompanyDrug

IASO Biotherapeutics’ Fucaso Granted Orphan Drug Designation by SFDA for Multiple Myeloma

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies
CompanyDeals

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies

BMS Q1 2025 Results: Opdivo Sales Up 12% Despite Overall Revenue Decline
Company

BMS Q1 2025 Results: Opdivo Sales Up 12% Despite Overall Revenue Decline

Anhui Anke's Allogeneic CAR-T Therapy UTAA09 Approved for r/r B-ALL Trials
CompanyDrug

Anhui Anke’s Allogeneic CAR-T Therapy UTAA09 Approved for r/r B-ALL Trials

Juventas Cell Therapy's CNCT 19 Gains NMPA Approval for Refractory Lupus Nephritis
CompanyDrug

Juventas Cell Therapy’s CNCT 19 Gains NMPA Approval for Refractory Lupus Nephritis

JW Therapeutics Enters Licensing Pact with Juno Therapeutics for sLVV Process
CompanyDeals

JW Therapeutics Enters Licensing Pact with Juno Therapeutics for sLVV Process

BRL Medicine Secures IND Approval for BRL-301 CAR-T Therapy in R/R B-NHL
CompanyDrug

BRL Medicine Secures IND Approval for BRL-301 CAR-T Therapy in R/R B-NHL

Show More